Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Grant or award Director acquired 18,838 shares (grant or award)
  2. 4 Grant or award Director acquired 18,838 shares (grant or award)
  3. 4 Grant or award Director acquired 18,838 shares (grant or award)
  4. 4 Grant or award Director acquired 18,838 shares (grant or award)
  5. 4 Grant or award Director acquired 18,838 shares (grant or award)
  6. 4 Grant or award Director acquired 18,838 shares (grant or award)
  7. 4 Grant or award Director acquired 18,838 shares (grant or award)
  8. 4 Grant or award Director acquired 18,838 shares (grant or award)
  9. 4 Grant or award Director acquired 10,015 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 425,000 shares at an average $20.55 ($8,733,955)
  12. 4 Open-market sale Director sold 27,280 shares at $21.12 ($576,154)
  13. 4 Open-market sale Director sold 11,686 shares at $20.96 ($244,939)
  14. 4 Open-market sale Director sold 11,437 shares at $21.00 ($240,177)
  15. 4 Shares withheld for taxes President and CEO gave up 73,943 shares (to pay taxes)
  16. 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 22,605 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, Commercial gave up 31,044 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 25,941 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP and CFO gave up 30,310 shares (to pay taxes)
  20. 4 Planned sale Director sold 10,923 shares at $21.37 ($233,425)

Page 8 of 73 · 1,458 filings